FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111348288> ?p ?o ?g. }

• W2111348288 endingPage "e482" @default.
• W2111348288 startingPage "e474" @default.
• W2111348288 abstract "Concerns have been raised about efavirenz reducing the effectiveness of contraceptive implants. We aimed to establish whether pregnancy rates differ between HIV-positive women who use various contraceptive methods and either efavirenz-based or nevirapine-based antiretroviral therapy (ART) regimens.We did this retrospective cohort study of HIV-positive women aged 15-45 years enrolled in 19 HIV care facilities supported by Family AIDS Care and Education Services in western Kenya between Jan 1, 2011, and Dec 31, 2013. Our primary outcome was incident pregnancy diagnosed clinically. The primary exposure was a combination of contraceptive method and efavirenz-based or nevirapine-based ART regimen. We used Poisson models, adjusting for repeated measures, and demographic, behavioural, and clinical factors, to compare pregnancy rates among women receiving different contraceptive and ART combinations.24,560 women contributed 37,635 years of follow-up with 3337 incident pregnancies. In women using implants, adjusted pregnancy incidence was 1.1 per 100 person-years (95% CI 0.72-1.5) for nevirapine-based ART users and 3.3 per 100 person-years (1.8-4.8) for efavirenz-based ART users (adjusted incidence rate ratio [IRR] 3.0, 95% CI 1.3-4.6). In women using depot medroxyprogesterone acetate, adjusted pregnancy incidence was 4.5 per 100 person-years (95% CI 3.7-5.2) for nevirapine-based ART users and 5.4 per 100 person-years (4.0-6.8) for efavirenz-based ART users (adjusted IRR 1.2, 95% CI 0.91-1.5). Women using other contraceptive methods, except for intrauterine devices and permanent methods, had 3.1-4.1 higher rates of pregnancy than did those using implants, with 1.6-2.8 higher rates in women using efavirenz-based ART.Although HIV-positive women using implants and efavirenz-based ART had a three-times higher risk of contraceptive failure than did those using nevirapine-based ART, these women still had lower contraceptive failure rates than did those receiving all other contraceptive methods except for intrauterine devices and permanent methods. Guidelines for contraceptive and ART combinations should balance the failure rates for each contraceptive method and ART regimen combination against the high effectiveness of implants.None." @default.
• W2111348288 created "2016-06-24" @default.
• W2111348288 creator A5002618601 @default.
• W2111348288 creator A5010600625 @default.
• W2111348288 creator A5011315383 @default.
• W2111348288 creator A5020589345 @default.
• W2111348288 creator A5031860394 @default.
• W2111348288 creator A5039805638 @default.
• W2111348288 creator A5040530822 @default.
• W2111348288 creator A5074052328 @default.
• W2111348288 creator A5083592650 @default.
• W2111348288 creator A5088830994 @default.
• W2111348288 date "2015-11-01" @default.
• W2111348288 modified "2023-10-15" @default.
• W2111348288 title "Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study" @default.
• W2111348288 cites W1673593636 @default.
• W2111348288 cites W1761275020 @default.
• W2111348288 cites W2000762428 @default.
• W2111348288 cites W2003223405 @default.
• W2111348288 cites W2026061386 @default.
• W2111348288 cites W2027240748 @default.
• W2111348288 cites W2028029127 @default.
• W2111348288 cites W2032049147 @default.
• W2111348288 cites W2037512793 @default.
• W2111348288 cites W2039855111 @default.
• W2111348288 cites W2040356795 @default.
• W2111348288 cites W2046043089 @default.
• W2111348288 cites W2049969210 @default.
• W2111348288 cites W2051345445 @default.
• W2111348288 cites W2055291483 @default.
• W2111348288 cites W2073540245 @default.
• W2111348288 cites W2081448332 @default.
• W2111348288 cites W2092562899 @default.
• W2111348288 cites W2097078637 @default.
• W2111348288 cites W2100296145 @default.
• W2111348288 cites W2101116561 @default.
• W2111348288 cites W2102680950 @default.
• W2111348288 cites W2131822813 @default.
• W2111348288 cites W2133001403 @default.
• W2111348288 cites W2136985213 @default.
• W2111348288 cites W2143508485 @default.
• W2111348288 cites W2144834223 @default.
• W2111348288 cites W2147229861 @default.
• W2111348288 cites W2148741820 @default.
• W2111348288 cites W2153826347 @default.
• W2111348288 cites W2281168691 @default.
• W2111348288 cites W2424408721 @default.
• W2111348288 doi "https://doi.org/10.1016/s2352-3018(15)00184-8" @default.
• W2111348288 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4632202" @default.
• W2111348288 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26520927" @default.
• W2111348288 hasPublicationYear "2015" @default.
• W2111348288 type Work @default.
• W2111348288 sameAs 2111348288 @default.
• W2111348288 citedByCount "62" @default.
• W2111348288 countsByYear W21113482882015 @default.
• W2111348288 countsByYear W21113482882016 @default.
• W2111348288 countsByYear W21113482882017 @default.
• W2111348288 countsByYear W21113482882018 @default.
• W2111348288 countsByYear W21113482882019 @default.
• W2111348288 countsByYear W21113482882020 @default.
• W2111348288 countsByYear W21113482882021 @default.
• W2111348288 countsByYear W21113482882022 @default.
• W2111348288 countsByYear W21113482882023 @default.
• W2111348288 crossrefType "journal-article" @default.
• W2111348288 hasAuthorship W2111348288A5002618601 @default.
• W2111348288 hasAuthorship W2111348288A5010600625 @default.
• W2111348288 hasAuthorship W2111348288A5011315383 @default.
• W2111348288 hasAuthorship W2111348288A5020589345 @default.
• W2111348288 hasAuthorship W2111348288A5031860394 @default.
• W2111348288 hasAuthorship W2111348288A5039805638 @default.
• W2111348288 hasAuthorship W2111348288A5040530822 @default.
• W2111348288 hasAuthorship W2111348288A5074052328 @default.
• W2111348288 hasAuthorship W2111348288A5083592650 @default.
• W2111348288 hasAuthorship W2111348288A5088830994 @default.
• W2111348288 hasBestOaLocation W21113482882 @default.
• W2111348288 hasConcept C120665830 @default.
• W2111348288 hasConcept C121332964 @default.
• W2111348288 hasConcept C126322002 @default.
• W2111348288 hasConcept C131872663 @default.
• W2111348288 hasConcept C142462285 @default.
• W2111348288 hasConcept C167135981 @default.
• W2111348288 hasConcept C167704817 @default.
• W2111348288 hasConcept C187212893 @default.
• W2111348288 hasConcept C201903717 @default.
• W2111348288 hasConcept C2779130552 @default.
• W2111348288 hasConcept C2779234561 @default.
• W2111348288 hasConcept C2781413609 @default.
• W2111348288 hasConcept C2781432083 @default.
• W2111348288 hasConcept C2908647359 @default.
• W2111348288 hasConcept C29456083 @default.
• W2111348288 hasConcept C2993143319 @default.
• W2111348288 hasConcept C3013748606 @default.
• W2111348288 hasConcept C512399662 @default.
• W2111348288 hasConcept C54355233 @default.
• W2111348288 hasConcept C61511704 @default.
• W2111348288 hasConcept C71924100 @default.
• W2111348288 hasConcept C86803240 @default.
• W2111348288 hasConcept C99454951 @default.

• next